Stocks analysis

Analysis for JPM

$335.53 +0.25 (+0.07%)
  • 📈 Growth — 29/30
  • 💰 Profitability — 19/20
  • 🏦 Financial Health — 14/20
  • 💵 Valuation — 12/20
  • ⚠️ Risk — 6/10
Overall Score: 78/100

Summary:


📈 Growth & Financial Trajectory

From 2024 Q2 to 2026 Q2, JPMorgan delivered a positive growth cadence. Revenue rose from $50.2B to $57.3B, about 14% growth. Net income climbed from $18.45B to $21.16B (~15%). The trend remains constructive despite quarterly variability, with a notable expansion in late 2025 into 2026 that coincides with stronger net interest income and fee-based revenue.

💰 Margins & Cash Flow

Operating margins held solidly in the high 30s to near 50% range; 2026 Q2 shows operating income $27.516B on $57.347B revenues, implying an approximate margin of 48%. This reflects operating leverage from interest income and efficiency gains. Net cash flow has been cyclical: quarters with sizable investing activity were cash-flow negative, while financing activity sometimes produced large inflows (e.g., 2025 Q4 net financing inflows around $400.677B).

🛡️ Balance Sheet & Liquidity

Bank-level balance sheet strength is evident: Assets ~ $5.0T, with Equity ~ $0.36T and a current-liabilities footprint of roughly $4.64T, yielding a near-unity current ratio (≈1.0). This structure supports liquidity, though leverage (liabilities far above equity) remains high by general corporate standards, as typical for a large bank.

⚠️ Key Drivers & Risks

  • Drivers: Robust net interest income and fee-based revenue underpin earnings; loan and deposit growth benefiting margins.
  • Risks: Credit cycle sensitivity and interest-rate shifts can affect provisions and earnings; macro conditions and regulatory changes can pressure funding costs and leverage.

📊 Key Financial Fundamentals

Valuation Multiples
Market Cap $927.49B
P/E Ratio 14.25
Forward P/E 14.03
P/S Ratio 2.90
P/B Ratio 2.32
EV / EBITDA N/A
Profitability & Returns
Gross Margin N/A
Operating Margin 41.23%
Net Margin 33.26%
ROE 17.81%
ROIC 4.43%
Financial Health & Liquidity
Current Ratio N/A
Quick Ratio N/A
Financial Scale & Cash Flow
Revenue $320.27B
Net Income $106.54B
FCF Yield 16.09%
Free Cash Flow $149.27B
Total Debt To Equity 3.30